Sanofi releases 2 clinical trial results for antidiabetic treatment

Sanofi Aventis Korea has unveiled two phase 3 clinical trial results for Soliqua (insulin glargine and lixisenatide injection), its antidiabetic treatment, at the European Association for the Study of Diabetes (EASD) 2018 Annual Meeting. The trials prese http://www.koreabiomed.com/news/articleView.html?idxno=4516